More on Treatment Outcomes in Multidrug-Resistant Tuberculosis

James C M Brust^{1

2}, N Sarita Shah³, Neel R Gandhi⁴

Affiliations

Comment

James C M Brust et al. N Engl J Med. 2016.

. 2016 Dec 29;375(26):2610.

doi: 10.1056/NEJMc1613123.

James C M Brust^{1

2}, N Sarita Shah³, Neel R Gandhi⁴

No abstract available

Comment in

More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.
Lange C, Günther G, van Leth F; TBNET. Lange C, et al. N Engl J Med. 2016 Dec 29;375(26):2611. doi: 10.1056/NEJMc1613123. N Engl J Med. 2016. PMID: 28029919 No abstract available.

Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance.
Zignol M, Dean AS, Falzon D, van Gemert W, Wright A, van Deun A, Portaels F, Laszlo A, Espinal MA, Pablos-Méndez A, Bloom A, Aziz MA, Weyer K, Jaramillo E, Nunn P, Floyd K, Raviglione MC. Zignol M, et al. N Engl J Med. 2016 Sep 15;375(11):1081-9. doi: 10.1056/NEJMsr1512438. N Engl J Med. 2016. PMID: 27626523 No abstract available.

1. World Health Organization. Definitions and reporting framework for tuberculosis --2013 revision. Geneva: WHO/HTM/TB/20132; 2013.
1. Laserson KF, Thorpe LE, Leimane V, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2005;9:640–5. - PubMed
1. Gunther G, Lange C, Alexandru S, et al. Treatment Outcomes in Multidrug-Resistant Tuberculosis. N Engl J Med. 2016;375:1103–5. - PubMed
1. Lu C, Liu Q, Sarma A, Fitzpatrick C, Falzon D, Mitnick CD. A systematic review of reported cost for smear and culture tests during multidrug-resistant tuberculosis treatment. PLoS One. 2013;8:e56074. - PMC - PubMed
1. Mitnick CD, White RA, Lu C, et al. Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method. Eur Respir J. 2016 - PMC - PubMed